Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.6100
-0.0197 (-3.13%)
At close: Apr 2, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $147.1 million as of April 2, 2026. Its market cap has increased by 10.73% in one year.
Market Cap
147.10M
Enterprise Value
96.34M
Revenue
237.26M
Ranking
n/a
PE Ratio
8.71
Stock Price
$0.61
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 147.10M, an increase of 143.75%. That is a compound annual growth rate of 11.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 147.10M | 76.96% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 334.07M |
| Northwest Biotherapeutics | 328.28M |
| Silence Therapeutics | 258.37M |
| HST Global | 88.40M |
| BioStem Technologies | 70.07M |
| Nuo Therapeutics | 70.02M |
| Vicapsys Life Sciences | 47.26M |
| Anebulo Pharmaceuticals | 39.96M |